PDS Biotechnology Corporation (PDSB) Total Return Calculator with Dividends Reinvested

PDS Biotechnology Corporation

Popular:

The total return for PDS Biotechnology Corporation (PDSB) stock is -45.39% over the past 12 months. So far it's up 4.90% this year. The 5-year total return is -91.84%, meaning $10,000 invested in PDSB stock 5 years ago would be worth $816 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in PDSB 1 year ago, it would be worth $6,680 today — you'd have lost $3,320.

With Dividends Reinvested$6,680-33.20%

Price Only (No DRIP)$6,680-33.20%

Period2025-06-30 → 2026-06-26

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in PDSB

1Y$5,461-$4,539 (-45.4%)-45.4% CAGR

3Y$1,642-$8,358 (-83.6%)-45.2% CAGR

5Y$816-$9,184 (-91.8%)-39.4% CAGR

10Y$48-$9,952 (-99.5%)-41.4% CAGR

15Y$40-$9,960 (-99.6%)-30.8% CAGR

20Y$40-$9,960 (-99.6%)-24.2% CAGR

30Y$40-$9,960 (-99.6%)-16.8% CAGR

PDS Biotechnology Corporation did not pay dividends during this period. Total return = price return.

Loading PDSB total return...

As of 2026-06-28

Performance Summary

Best Year+255.26%2021

Worst Year-96.82%2018

Max Drawdown-63.00%2025-06-24 → 2026-03-30

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+4.90%	—	+6.66%	—	$10,490
1Y	-45.39%	-45.39%	-38.72%	—	$5,461
3Y	-83.58%	-45.24%	-83.30%	—	$1,642
5Y	-91.84%	-39.42%	-92.41%	+0.57 pp	$816
10Y	-99.52%	-41.43%	-99.49%	—	$48
15Y	-99.60%	-30.83%	-99.60%	—	$40
20Y	-99.60%	-24.15%	-99.60%	—	$40
30Y	-99.60%	-16.83%	-99.60%	—	$40

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-18.97%	-18.97%	—	+0.41%	-19.4pp
2025	-55.49%	-55.49%	—	+16.64%	-72.1pp
2024	-68.35%	-68.35%	—	+24.00%	-92.3pp
2023	-53.20%	-53.20%	—	+24.81%	-78.0pp
2022	+56.58%	+56.58%	—	-19.95%	+76.5pp

PDSB underperformed the S&P 500 by 66.23pp over the past year (-45.39% vs +20.84%).

Loading summary...

PDSB Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
PDSBPDS Biotechnology Corporation	$50M	-19.2%	+4.9%	-45.4%	—	-83.6%	-91.8%	-99.5%
IMVTImmunovant, Inc.	$8.0B	+14.8%	+47.5%	+138.9%	—	+98.5%	+247.5%	+284.1%
NKTRNektar Therapeutics	$1.2B	-2.9%	+49.5%	+165.4%	—	+621.1%	-74.6%	-69.9%
IOVAIovance Biotherapeutics, Inc.	$1.5B	+3.7%	+68.5%	+125.8%	—	-43.6%	-83.7%	-46.0%
NVAXNovavax, Inc.	$1.5B	-15.1%	+24.8%	+37.1%	—	+33.4%	-95.4%	-93.3%
OCGNOcugen, Inc.	$508M	+11.9%	+0.7%	+35.0%	—	+183.7%	-83.0%	-98.7%
IMCRImmunocore Holdings plc	$1.6B	+5.0%	-11.2%	-6.3%	—	-46.7%	-18.2%	-30.6%
NUVBNuvation Bio Inc.	$2.0B	+20.5%	-24.7%	+215.1%	—	+271.3%	-33.5%	-35.4%
AGENAgenus Inc.	$126M	-8.7%	-9.6%	-41.6%	—	-91.1%	-97.3%	-96.3%
HALOHalozyme Therapeutics, Inc.	$8.9B	+9.1%	+1.2%	+32.0%	—	+104.2%	+56.2%	+743.0%
CLDXCelldex Therapeutics, Inc.	$2.3B	+14.3%	+25.1%	+56.0%	—	-4.4%	+5.6%	-48.3%

Compare:PDSB vs IMVT PDSB vs NKTR PDSB vs IOVA PDSB vs IMVT vs NKTR

About PDSB Dividend Returns

PDS Biotechnology Corporation (PDSB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of PDSB over the past year?

PDS Biotechnology Corporation (PDSB) delivered a return of -45.39% over the past year. Since PDSB does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in PDSB be worth today?

A $10,000 investment in PDS Biotechnology Corporation one year ago would be worth $5,461 today, representing a loss of $4,539.

Q3Does PDSB pay dividends?

PDS Biotechnology Corporation (PDSB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For PDSB, the total return equals the price-only return.

Q4Did PDSB beat the S&P 500?

No, PDS Biotechnology Corporation (PDSB) underperformed the S&P 500 by 66.23 percentage points over the past year. PDSB delivered a total return of -45.39%, compared to the S&P 500's 20.84%. This means a passive S&P 500 index fund outperformed PDSB by 66.23pp during this period.

Q5What is PDSB's worst drawdown?

PDS Biotechnology Corporation (PDSB) experienced a maximum drawdown of -63.00% over the past year, declining from its peak on 2025-06-24 to its trough on 2026-03-30. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is PDSB's long-term total return over 10, 20, or 30 years?

Here are PDS Biotechnology Corporation (PDSB)'s long-term returns with dividends reinvested. Over 10 years, the total return is -99.5% (-41.4% CAGR) — $10,000 would have grown to $48. Over 20 years: -99.6% total return (-24.2% CAGR) — $10,000 → $40. Over 30 years: -99.6% total return (-16.8% CAGR) — $10,000 → $40. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was PDSB's best and worst year?

PDS Biotechnology Corporation's best calendar year was 2021 with a total return of 255.3%. Its worst year was 2018 with a total return of -96.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 352.1 percentage points.

How much would $100/month in PDSB be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →